These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 32291351)

  • 1. Repurposing Didanosine as a Potential Treatment for COVID-19 Using Single-Cell RNA Sequencing Data.
    Alakwaa FM
    mSystems; 2020 Apr; 5(2):. PubMed ID: 32291351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Repurposable drugs for SARS-CoV-2 and influenza sepsis with scRNA-seq data targeting post-transcription modifications.
    Wang Z; Guo K; Gao P; Pu Q; Li C; Hur J; Wu M
    Precis Clin Med; 2021 Dec; 4(4):215-230. PubMed ID: 34993416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of new drug treatments to combat COVID19: A signature-based approach using iLINCS.
    O'Donovan SM; Eby H; Henkel ND; Creeden J; Imami A; Asah S; Zhang X; Wu X; Alnafisah R; Taylor RT; Reigle J; Thorman A; Shamsaei B; Meller J; McCullumsmith RE
    Res Sq; 2020 Apr; ():. PubMed ID: 32702077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of Repurposable Drugs and Adverse Drug Reactions for Various Courses of COVID-19 Based on Single-Cell RNA Sequencing Data.
    Wang Z; Guo K; Gao P; Pu Q; Wu M; Li C; Hur J
    ArXiv; 2020 May; ():. PubMed ID: 33299905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Repurposed Drugs as Potential Therapeutic Candidates for the Management of Alzheimer's Disease.
    Shoaib M; Kamal MA; Rizvi SMD
    Curr Drug Metab; 2017; 18(9):842-852. PubMed ID: 28595531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In silico Drug Repurposing to combat COVID-19 based on Pharmacogenomics of Patient Transcriptomic Data.
    Das S; Camphausen K; Shankavaram U
    Res Sq; 2020 Jun; ():. PubMed ID: 32702730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tripartite Combination of Candidate Pandemic Mitigation Agents: Vitamin D, Quercetin, and Estradiol Manifest Properties of Medicinal Agents for Targeted Mitigation of the COVID-19 Pandemic Defined by Genomics-Guided Tracing of SARS-CoV-2 Targets in Human Cells.
    Glinsky GV
    Biomedicines; 2020 May; 8(5):. PubMed ID: 32455629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ASGARD: A Single-cell Guided pipeline to Aid Repurposing of Drugs.
    He B; Xiao Y; Liang H; Huang Q; Du Y; Li Y; Garmire D; Sun D; Garmire LX
    ArXiv; 2021 Sep; ():. PubMed ID: 34545335
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    López-Cortés A; Guevara-Ramírez P; Kyriakidis NC; Barba-Ostria C; León Cáceres Á; Guerrero S; Ortiz-Prado E; Munteanu CR; Tejera E; Cevallos-Robalino D; Gómez-Jaramillo AM; Simbaña-Rivera K; Granizo-Martínez A; Pérez-M G; Moreno S; García-Cárdenas JM; Zambrano AK; Pérez-Castillo Y; Cabrera-Andrade A; Puig San Andrés L; Proaño-Castro C; Bautista J; Quevedo A; Varela N; Quiñones LA; Paz-Y-Miño C
    Front Pharmacol; 2021; 12():598925. PubMed ID: 33716737
    [No Abstract]   [Full Text] [Related]  

  • 10. Challenges for Drug Repurposing in the COVID-19 Pandemic Era.
    Sultana J; Crisafulli S; Gabbay F; Lynn E; Shakir S; Trifirò G
    Front Pharmacol; 2020; 11():588654. PubMed ID: 33240091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Review of Repurposed Cancer Drugs in Clinical Trials for Potential Treatment of COVID-19.
    Costa B; Vale N
    Pharmaceutics; 2021 May; 13(6):. PubMed ID: 34070725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An OpenData portal to share COVID-19 drug repurposing data in real time.
    Brimacombe KR; Zhao T; Eastman RT; Hu X; Wang K; Backus M; Baljinnyam B; Chen CZ; Chen L; Eicher T; Ferrer M; Fu Y; Gorshkov K; Guo H; Hanson QM; Itkin Z; Kales SC; Klumpp-Thomas C; Lee EM; Michael S; Mierzwa T; Patt A; Pradhan M; Renn A; Shinn P; Shrimp JH; Viraktamath A; Wilson KM; Xu M; Zakharov AV; Zhu W; Zheng W; Simeonov A; Mathé EA; Lo DC; Hall MD; Shen M
    bioRxiv; 2020 Jun; ():. PubMed ID: 32511420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Snapshot of the Global Race for Vaccines Targeting SARS-CoV-2 and the COVID-19 Pandemic.
    Funk CD; Laferrière C; Ardakani A
    Front Pharmacol; 2020; 11():937. PubMed ID: 32636754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug Repurposing for the Treatment of COVID-19: A Knowledge Graph Approach.
    Yan VKC; Li X; Ye X; Ou M; Luo R; Zhang Q; Tang B; Cowling BJ; Hung I; Siu CW; Wong ICK; Cheng RCK; Chan EW
    Adv Ther (Weinh); 2021 Jul; 4(7):2100055. PubMed ID: 34179346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccines and Drug Therapeutics to Lock Down Novel Coronavirus Disease 2019 (COVID-19): A Systematic Review of Clinical Trials.
    Bhagavathula AS; Aldhaleei WA; Rovetta A; Rahmani J
    Cureus; 2020 May; 12(5):e8342. PubMed ID: 32494546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. QUADrATiC: scalable gene expression connectivity mapping for repurposing FDA-approved therapeutics.
    O'Reilly PG; Wen Q; Bankhead P; Dunne PD; McArt DG; McPherson S; Hamilton PW; Mills KI; Zhang SD
    BMC Bioinformatics; 2016 May; 17(1):198. PubMed ID: 27143038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploration of the Anti-Inflammatory Drug Space Through Network Pharmacology: Applications for Drug Repurposing.
    de Anda-Jáuregui G; Guo K; McGregor BA; Hur J
    Front Physiol; 2018; 9():151. PubMed ID: 29545755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ASGARD is A Single-cell Guided Pipeline to Aid Repurposing of Drugs.
    He B; Xiao Y; Liang H; Huang Q; Du Y; Li Y; Garmire D; Sun D; Garmire LX
    Nat Commun; 2023 Feb; 14(1):993. PubMed ID: 36813801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-based virtual screening of phytochemicals and repurposing of FDA approved antiviral drugs unravels lead molecules as potential inhibitors of coronavirus 3C-like protease enzyme.
    Bahadur Gurung A; Ajmal Ali M; Lee J; Abul Farah M; Mashay Al-Anazi K
    J King Saud Univ Sci; 2020 Sep; 32(6):2845-2853. PubMed ID: 32837113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An Application of Computational Drug Repurposing Based on Transcriptomic Signatures.
    Karatzas E; Kolios G; Spyrou GM
    Methods Mol Biol; 2019; 1903():149-177. PubMed ID: 30547441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.